Eurocaps Limited

13 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• FALSE6 refused lines

  False or misleading labeling

  The labeling appeared to be false or misleading in some particular.

• UNAPPROVED6 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• DIRSEXMPT4 refused lines

  DIRSEXMPT

• DIRECTIONS1 refused line

  DIRECTIONS

• HEALTH C1 refused line

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

Questions about Eurocaps Limited

Is Eurocaps Limited on an FDA import alert?

Yes. As of October 26, 2026, Eurocaps Limited is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for lumity morning; dietary supplement; FDA published the listing on March 18, 2016.

Has FDA refused shipments from Eurocaps Limited?

Yes. FDA refused 11 shipment lines from Eurocaps Limited between March 1, 2017 and July 23, 2021. The most recent, on July 23, 2021, was herbals & botanicals (not teas), n.e.c., charged as DIRSEXMPT (dirsexmpt).

Why did FDA refuse Eurocaps Limited's shipments?

The most frequent charges are FALSE (false or misleading labeling, 6 lines) and UNAPPROVED (unapproved new drug, 6 lines).

When was Eurocaps Limited last inspected by FDA?

FDA's most recent inspection of Eurocaps Limited with a final classification is dated October 21, 2011 and was classified NAI (No Action Indicated).

What is Eurocaps Limited's FEI number?

Eurocaps Limited's FDA Establishment Identifier (FEI) is 3004315762.

Can shipments from Eurocaps Limited still enter the U.S.?

Shipments of lumity morning; dietary supplement from Eurocaps Limited can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).